| Bioactivity | Ritobegron, a prodrug of the active compound, KUC-7322, is a selective β3 -adrenoceptor agonist. Ritobegron decreases intravesical pressure with minimal effects on the cardiovascular system. |
| CAS | 476333-91-2 |
| Formula | C23H32ClNO5 |
| Molar Mass | 437.96 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Maruyama I, Goi Y, Tatemichi S, et al. Bladder selectivity of the novel β₃-agonist ritobegron (KUC-7483) explored by in vitro and in vivo studies in the rat. Naunyn Schmiedebergs Arch Pharmacol. 2012;385(8):845-852. [2]. Maruyama I, Tatemichi S, Goi Y, et al. Effects of ritobegron (KUC-7483), a novel selective β3-adrenoceptor agonist, on bladder function in cynomolgus monkey. J Pharmacol Exp Ther. 2012;342(1):163-168. |
Ritobegron hydrochloride
CAS: 476333-91-2 F: C23H32ClNO5 W: 437.96
Ritobegron, a prodrug of the active compound, KUC-7322, is a selective β3 -adrenoceptor agonist.Ritobegron decreases in
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.